I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Impact of methodological choices in comparative effectivene..:
Lefort, Mathilde
;
Sharmin, S
;
Andersen, J
...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12874-022-01623-8. , 2022
Link:
https://univ-rennes.hal.science/hal-03690493
RT Journal T1
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis
UL https://suche.suub.uni-bremen.de/peid=base-ftunivlyon1:oai:HAL:hal-03690493v1&Exemplar=1&LAN=DE A1 Lefort, Mathilde A1 Sharmin, S A1 Andersen, J A1 Vukusic, S A1 Casey, R A1 Debouverie, M A1 Edan, G A1 Ciron, J A1 Ruet, A A1 de Sèze, J A1 Maillart, E A1 Zephir, H A1 Labauge, Pierre A1 Defer, G A1 Lebrun-Frenay, C A1 Moreau, T A1 Berger, E A1 Clavelou, P A1 Pelletier, J A1 Stankoff, B A1 Gout, O A1 Thouvenot, Eric A1 Heinzlef, O A1 Al-Khedr, A A1 Bourre, B A1 Casez, O A1 Cabre, P A1 Montcuquet, A A1 Wahab, A A1 Camdessanché, J A1 Maurousset, A A1 Ben Nasr, H A1 Hankiewicz, K A1 Pottier, C A1 Maubeuge, N A1 Dimitri-Boulos, D A1 Nifle, C A1 Laplaud, D A1 Horakova, D A1 Havrdova, E A1 Alroughani, R A1 Izquierdo, G A1 Eichau, S A1 Ozakbas, S A1 Patti, F A1 Onofrj, M A1 Lugaresi, A A1 Terzi, M A1 Grammond, P A1 Grand'Maison, F A1 Yamout, B A1 Prat, A A1 Girard, M A1 Duquette, P A1 Boz, C A1 Trojano, M A1 Mccombe, P A1 Slee, M A1 Lechner-Scott, J A1 Turkoglu, R A1 Sola, P A1 Ferraro, D A1 Granella, F A1 Shaygannejad, V A1 Prevost, J A1 Maimone, D A1 Skibina, O A1 Buzzard, K A1 van Der Walt, A A1 Karabudak, R A1 van Wijmeersch, B A1 Csepany, T A1 Spitaleri, D A1 Vucic, S A1 Koch-Henriksen, N A1 Sellebjerg, F A1 Soerensen, P A1 Hilt Christensen, C A1 Rasmussen, P A1 Jensen, M A1 Frederiksen, J A1 Bramow, S A1 Mathiesen, H A1 Schreiber, K A1 Butzkueven, H A1 Magyari, M A1 Kalincik, T A1 Leray, Emmanuelle PB HAL CCSD; BioMed Central YR 2022 K1 Causal contrasts K1 Censoring K1 Effectiveness K1 Indication bias K1 Multiple sclerosis K1 Positivity assumption K1 Propensity score K1 MESH: Fingolimod Hydrochloride K1 MESH: Humans K1 MESH: Multiple Sclerosis K1 Relapsing-Remitting K1 MESH: Natalizumab K1 MESH: Treatment Outcome K1 [SDV]Life Sciences [q-bio] JF info:eu-repo/semantics/altIdentifier/doi/10.1186/s12874-022-01623-8 LK http://dx.doi.org/https://univ-rennes.hal.science/hal-03690493 DO https://univ-rennes.hal.science/hal-03690493 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)